---
schema_version: "secwatch.filing_event.v1"
accession: "0000014272-25-000147"
form_type: "8-K"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:17:35.851531+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bristol Myers Q3 revenue $12.2B (+3% YoY), GAAP EPS $1.08, raises FY revenue guidance to ~$47.5-48B

## Summary
- Total revenues $12,222M (+3% YoY; +2% ex-FX); Growth Portfolio $6.9B (+18% ex-FX).
- GAAP EPS $1.08 (up 81% YoY); non-GAAP EPS $1.63 (down 9% YoY); both include $(0.20) net impact from Acquired IPRD and licensing.
- FY 2025 revenue guidance raised to ~$47.5B-$48.0B; non-GAAP EPS expected $6.40-$6.60 (includes $(0.80) net Acquired IPRD impact).
- Q3 2024 comparatives: revenue $11,892M, GAAP EPS $0.60, non-GAAP EPS $1.80.
- CEO cites Growth Portfolio momentum, pipeline advancements, and strategic business development.

## SEC filing metadata
- accession: 0000014272-25-000147
- form_type: 8-K
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/0000014272-25-000147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/bmy-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000014272-25-000147
- JSON: https://secwatch.observer/filing/0000014272-25-000147.json
- Plain text: https://secwatch.observer/filing/0000014272-25-000147.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.